Paolo Provenzano (@ppproven) 's Twitter Profile
Paolo Provenzano

@ppproven

#Bioengineer and #quantitative #biologist, dedicated to understanding and fighting #cancer. Professor, Dept. of #Biomedical #Engineering

ID: 385642271

linkhttp://provenzanolab.umn.edu calendar_today05-10-2011 21:19:58

675 Tweet

717 Followers

523 Following

Paolo Provenzano (@ppproven) 's Twitter Profile Photo

Extremely excited and honored to have been able to collaborate with the@DeNardoLabWUSMon the impact of senCAFs in #pancreaticcancer Deeply exciting work! Check it out: aacrjournals.org/cancerdiscover…

Extremely excited and honored to have been able to collaborate with the@DeNardoLabWUSMon the impact of senCAFs in #pancreaticcancer  Deeply exciting work!  Check it out: aacrjournals.org/cancerdiscover…
Mara Sherman Lab (@marashermanlab) 's Twitter Profile Photo

Motivation Monday! Check out these brilliant studies from David DeNardo WUSM Sheila Stewart hot off the press focused on tissue-specific, immune-modulatory fxns of senescent CAFs! 🤩

NCI Division of Cancer Biology (@ncicancerbio) 's Twitter Profile Photo

During her talk, Dr. Edna Cukierman, Ph.D. is showing that pulsed low-dose-rate radiation (PLDR) reduces the tumor-promoting responses induced by chemoradiation in #PancreaticCancer-associated fibroblasts. Read more in bioRxiv: biorxiv.org/content/10.110… #SMC3B

NCI Division of Cancer Biology (@ncicancerbio) 's Twitter Profile Photo

During her presentation, Sheila Stewart is showing that senescent cancer-associated fibroblasts suppress Natural Killer cell activity and promote #BreastCancer progression in preclinical models. Read more in a recent Cancer Discovery study: aacrjournals.org/cancerdiscover… #SMC3B #BCSM

NCI Division of Cancer Biology (@ncicancerbio) 's Twitter Profile Photo

Using preclinical models in an National Cancer Institute funded study, Marina Broz, Jlenia Guarnerio, et al. showed that metabolic targeting of cancer-associated fibroblasts (#CAFs) overcomes T-cell exclusion and treatment resistance in soft-tissue #sarcomas Nature Communications nature.com/articles/s4146….

Using preclinical models in an <a href="/theNCI/">National Cancer Institute</a> funded study, <a href="/marina_broz/">Marina Broz</a>, <a href="/JleniaGuarnerio/">Jlenia Guarnerio</a>, et al. showed that metabolic targeting of cancer-associated fibroblasts (#CAFs) overcomes T-cell exclusion and treatment resistance in soft-tissue #sarcomas <a href="/NatureComms/">Nature Communications</a> nature.com/articles/s4146….
Fischbach Lab (@fischbachlab) 's Twitter Profile Photo

Congrats to Shola Karimu 👩🏿‍🔬 🇹🇬🇳🇬 for receiving the Robert Mozia Graduate Service Award! ABSOLUTELY deserved! We are so fortunate to have Shola and her joyous energy for science and for life in our lab

UMN Biomedical Eng (@umnbme) 's Twitter Profile Photo

Building a new medical device from scratch: A The Minnesota Star Tribune story shares how a team of #UMN student inventors & a UMN Biomedical Eng faculty member answered a patient’s call for help. ➡️Story: bit.ly/4bmhsH8 College of Sci & Eng U of M Research University of Minnesota Law School UMN Medical School startribune.com/no-funding-no-…

Howard Crawford (@hccvpdac) 's Twitter Profile Photo

I can’t say enough good things about this meeting! It all started as a conversation on Twitter a year ago (maybe less?) Turned quickly and efficiently into a reality by Kay and her colleagues UChicagoCancerCenter . Great venue & stellar colleagues! Absolutely amazing!

Aguirre-Ghiso Lab (@jaguirreghiso) 's Twitter Profile Photo

I said it many times, but this time it was Dr. Weinberg et al "The major challenge of current metastasis research is to understand how rare disseminated tumour cells (DTCs) succeed in metastatic colonization..." Nice highlights CDTMI_Einstein science. nature.com/articles/s4155…

nature (@nature) 's Twitter Profile Photo

Three scientist mothers call for a change in how conference childcare costs are reimbursed, drawing on their personal experiences go.nature.com/3KfWZIB

Kevin Tharp (@derpology) 's Twitter Profile Photo

If you're interested in anti-tumor immunity and metabolism... Arg:Orn ⚖️ TAM/CD8 Article: nature.com/articles/s4301… News and Views: nature.com/articles/s4301…

NCI PhysicalSciences (@nciphysci) 's Twitter Profile Photo

Dr. Kevin Eliceiri, Paolo Provenzano, et al. at the University of Minnesota #CCBIR Center for Multiparametric Imaging of Tumor Immune Microenvironments are advancing live-cell and tissue #imaging platforms to characterize barriers that limit antitumor immunity & #immunotherapy. cancer.gov/about-nci/orga…

Dr. Kevin Eliceiri, <a href="/ppproven/">Paolo Provenzano</a>, et al. at the <a href="/UMNews/">University of Minnesota</a> #CCBIR Center for Multiparametric Imaging of Tumor Immune Microenvironments are advancing live-cell and tissue #imaging platforms to characterize barriers that limit antitumor immunity &amp; #immunotherapy. cancer.gov/about-nci/orga…
Alana Welm (@alanawelm) 's Twitter Profile Photo

I’m honored and excited to lead Metastasis Research Society for the next two years along with Pres-Elect Neta Erez- ErezLab🎗️ ! Thank you eriksahailab for a fantastic conference and eager to host you all in 2 years in #beautahful Utah near Huntsman Cancer Institute !!

E. John Wherry (@ejohnwherry) 's Twitter Profile Photo

Very happy to share this new work on LAG3 and PD1. Has been a long road to (begin to) sort out how LAG3 functions in CD8 T cell exhaustion. Great work by Shin Ngiow and super collaboration (and 2 other great papers) with Vignali Lab and Dario Vignali cell.com/cell/abstract/…

Hans Clevers (@hansclevers) 's Twitter Profile Photo

Astonishing breakthrough in #organoid engineering, as reported in nature by T Recaldin,M Harter,L Steinacher,B Gjeta, and colleagues: intestinal epithelial organoids incorporating tissue-resident immune cells. Institute of Human Biology Roche go.roche.com/4a5t1

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

The company ran a 240 patient (!) randomized phase 2 trial of Simtuzumab in #PancreaticCancer that showed no therapeutic benefit. academic.oup.com/oncolo/article… As an angiogenesis inhibitor (versus the stated inhibition of LOXL2 catalytic activity) this was essentially a rerun of Gem